pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,356 catalysts · 5,063 phase readout · 2,344 8k filing · 293 pdufa · 283 earnings · 115 phase 2 completion · 53 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 31 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout5,063
  • 8k filing2,344
  • pdufa293
  • earnings283
  • phase 2 completion115
  • phase 1 completion53
  • phase 1 2 completion
28
  • phase 1 initiation26
  • phase 0 trial completion22
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07031791: PETRA: Pictorial Assessment of Task Occurrence and Upper Limb Avoidance Behaviors

    Sponsor: University Hospital, Angers. Phase: . Conditions: Thoraco-brachial Outlet Syndrome, ADAP-shoulder Scale, PETRA

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07325591: Efficacy and Safety of Tazbentetol in ALS Participants

    Sponsor: Spinogenix. Phase: PHASE2. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07556874: Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas

    Sponsor: Istituto Ortopedico Rizzoli. Phase: . Conditions: Multiple Osteochondroma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07494318: Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.

    Sponsor: Methodist Health System. Phase: . Conditions: Gastro-Intestinal Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03108118: Diaphragm Injury and Dysfunction During Mechanical Ventilation

    Sponsor: University Health Network, Toronto. Phase: . Conditions: Respiratory Insufficiency, Diaphragm Injury, Mechanical Ventilation Complication

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07334197: Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy

    Sponsor: Tanta University. Phase: NA. Conditions: Ppm, Cardiomyopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06567860: Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

    Sponsor: La Jolla Institute for Immunology. Phase: PHASE4. Conditions: Influenza A

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07396220: Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation

    Sponsor: University of California, San Diego. Phase: NA. Conditions: Suicidal Ideation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06617182: Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

    Sponsor: Yongquan Shi. Phase: PHASE2. Conditions: Radiation Enteritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07484724: A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

    Sponsor: Shanghai Junshi Bioscience Co., Ltd.. Phase: PHASE2. Conditions: Advanced Esophageal Squamous Cell Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06628323: Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory Hallucinations

    Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: NA. Conditions: Auditory Hallucinations, Schizophrenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07598123: Effects of Multi-component Exercise on Physical Performance and Sleep Quality in Older Adults

    Sponsor: Tunghai University. Phase: NA. Conditions: Aging, Sleep Quality, Physical Performance

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06692959: A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer

    Sponsor: University of Southampton. Phase: PHASE2. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT02893059: Evaluation of a Data Collection Tool in Clinical Research: Comparison Between the Data Collected by Patient Diary and Data From Medical Administrative Databases

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Case Report Form, Declaration Bias, Health Insurance Database

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04027296: Development and Validation of the GLORI-COPD Score

    Sponsor: University of Paris 5 - Rene Descartes. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05327296: Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)

    Sponsor: Sedana Medical. Phase: PHASE3. Conditions: Sedation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07504796: ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

    Sponsor: NYU Langone Health. Phase: PHASE4. Conditions: Metastatic Melanoma, Advanced Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05710679: Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer

    Sponsor: Centre Jean Perrin. Phase: NA. Conditions: Locally Advanced Head and Neck Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06274879: Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE2. Conditions: Bile Duct Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06133062: Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma

    Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma Non-resectable

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07351227: Pediatric Airway: Noninferiority Trial of Devices for Intubation Assessment

    Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Intubation, Intratracheal, Airway Management, Video Laryngoscope, Cost Effectiveness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07476703: Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

    Sponsor: Danderyd Hospital. Phase: . Conditions: Coronary Artery Disease, Arterial Stiffness, Blood Pressure, AORTIC VALVE DISEASES, Mitral Valve Stenosis and/or Insufficiency, Heart Failure, Pulmonary Disease, Chronic Obstructive (COPD), Steatohepatitis, Inflammation Biomarkers, Lipid Profile, Oral Microbiota, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Associated-dysfunction Steatohepatitis (MASH)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06204003: Cannabinoids for Pain Management and Neuroprotection From Concussion

    Sponsor: University of Regina. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04816227: Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05553327: Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

    Sponsor: Hospital Clinic of Barcelona. Phase: NA. Conditions: Prostate Cancer, Radical Prostatectomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06883942: Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.

    Sponsor: Fondazione Don Carlo Gnocchi ETS. Phase: . Conditions: Lower Limb Amputation, Slip Perturbations, Fall Risk

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03155386: Optimized Angiomammography and Comparison With Standard Angiomammography

    Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: . Conditions: Patients for Whom an Angiomammogram Examination is Requested Whether Its Indication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05228470: A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

    Sponsor: Pfizer. Phase: PHASE2. Conditions: Elranatamab, Myeloma, Multiple Myeloma, Relapsed Multiple Myeloma, Refractory Multiple Myeloma, PF-06863135, BCMA, Bispecific, Bispecific Antibody, BCMA-CD3 Bispecific, MagnetisMM-8

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05748873: Promising ROd-cone DYstrophy Gene therapY

    Sponsor: SparingVision. Phase: PHASE1. Conditions: Retinitis Pigmentosa

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05471973: CIED Infection Quality Initiative Demonstration Project

    Sponsor: Duke University. Phase: NA. Conditions: Infections

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03364569: Usefullness of Peri-operative Tranexamic Acid in Primary Breast Augmentation With Implants.

    Sponsor: Hôpital NOVO. Phase: . Conditions: Plastic Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05819541: Treating Exacerbations of Asthma With Oral Montelukast in Children

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Status Asthmaticus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05228041: BIOlogics in Severe Nasal POlyposis SurvEy

    Sponsor: University Hospital, Lille. Phase: . Conditions: Chronic Rhinosinusitis With Nasal Polyps

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05515341: A DirEct to PatieNt Study in Chronic Pain

    Sponsor: Boston Scientific Corporation. Phase: . Conditions: Chronic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07512154: Precision Radiotherapy Enabled by Molecular MRI

    Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: NA. Conditions: Brain Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06273605: The Egg Up Trial - Testing a New Treatment Pathway for Infants With Newly Diagnosed Egg Allergy

    Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Food Allergy, Food Allergy in Infants

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05346354: Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

    Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Neuromyelitis Optica Spectrum Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05351905: Improving Pain Disability With the Use of Oral Cannabinoids

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Chronic Pain, Opioid Use, Cannabis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07574294: Dual REmission in Moderate-to-SEvere asthMa and Nasal Polyps

    Sponsor: Azienda Ulss 2 Marca Trevigiana. Phase: . Conditions: Asthma, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07615283: Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma

    Sponsor: Sun Yat-sen University. Phase: PHASE1. Conditions: Relapsed or Refractory Peripheral T Cell Lymphoma, NKTCL

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06585683: Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008

    Sponsor: COVID-19 Prevention Network. Phase: . Conditions: Tuberculosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07407894: iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

    Sponsor: Synbiotic Health. Phase: NA. Conditions: Healthy Aging, Anti Aging

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00690066: PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)

    Sponsor: Mesoblast, Inc.. Phase: PHASE2. Conditions: Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent, Juvenile Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07322302: RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Trachoma, Eye Diseases, Trichiasis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07079631: A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

    Sponsor: BioNTech SE. Phase: PHASE1. Conditions: Metastatic Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06420531: Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Prematurity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04946253: SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care

    Sponsor: University of Pittsburgh. Phase: NA. Conditions: Child Behavior Problem, Attention Deficit and Disruptive Behavior Disorders

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05175053: Early RRT in AKI After Cardiac Surgery

    Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Acute Kidney Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07512245: Assessment of Two Soft Tissue Augmentation Using Acellular Dermis Around Dental Implants

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Acellular Dermal Matrix, Alveolar Mucosa

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02583672: Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)

    Sponsor: University of Minnesota. Phase: PHASE2. Conditions: Gaucher Disease Type 1

    full page →ctgov ↗
    ← prev
    page 93 of 108
    next →